Publications by authors named "M Rumpf"

Three-dimensional (3D) imaging has advanced basic research and clinical medicine. However, limited resolution and imperfections of real-world 3D image material often preclude algorithmic image analysis. Here, we present a methodologic framework for such imaging and analysis for functional and spatial relations in experimental nephritis.

View Article and Find Full Text PDF

Microtubule-Associated Serine/Threonine (MAST) kinases represent an evolutionary conserved branch of the AGC protein kinase superfamily in the kinome. Since the discovery of the founding member, MAST2, in 1993, three additional family members have been identified in mammals and found to be broadly expressed across various tissues, including the brain, heart, lung, liver, intestine and kidney. The study of MAST kinases is highly relevant for unraveling the molecular basis of a wide range of different human diseases, including breast and liver cancer, myeloma, inflammatory bowel disease, cystic fibrosis and various neuronal disorders.

View Article and Find Full Text PDF

Charcot-Marie-Tooth disease type 1A (CMT1A) is the most prevalent hereditary demyelinating neuropathy. This autosomal, dominantly inherited disease is caused by a duplication on chromosome 17p which includes the peripheral myelin protein 22 (PMP22) gene. There is clinical evidence that the disability in CMT1A is to a large extend due to axonal damage rather than demyelination.

View Article and Find Full Text PDF

Effective directional change in sport is imperative to success in key game situations. Change of direction (COD) ability is underpinned by various athletic qualities which can be developed through specific and non-specific training methods. This review examined the effect of specific and non-specific training methods on pro-agility performance, by analysing the intervention type and resulting magnitude of training effects on pro-agility shuttle performance.

View Article and Find Full Text PDF
Article Synopsis
  • The SARS-CoV-2 pandemic highlighted the need for quick and effective diagnostic tools, especially for detecting neutralizing antibodies after infection or vaccination.
  • Current testing methods take hours and often require specialized facilities, which limits their accessibility.
  • A new competitive chemiluminescence immunoassay has been developed that can detect neutralizing antibodies in just 7 minutes, showing effective performance in comparison to traditional and commercial tests, and holds potential for adaptation to other diseases.
View Article and Find Full Text PDF